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Abstract
Background—The question of how smoking, COPD, and other chronic diseases are related 
remains unresolved. Therefore, we examined relationships between smoking, COPD, and 10 other 
chronic diseases and assessed the prevalence of co-morbid chronic conditions among people with 
COPD.
Methods—We analyzed cross-sectional data from 405,856 US adults aged 18 years or older in 
the 2011 Behavioral Risk Factor Surveillance System. We used log-linear regression to estimate 
prevalence ratios (PRs) and their corresponding 95% confidence intervals (CIs) for these 
relationships adjusting for age, gender, race/ethnicity, marital status, educational attainment, 
annual household income, and health insurance coverage.
Results—Overall, 17.5% reported being current cigarette smokers, 6.9% reported having COPD, 
and 71.2% reported another chronic condition. After age-adjustment, prevalence of COPD was 
14.1% (adjusted PR = 3.9; 95% CI: 3.7, 4.1) among current smokers and 7.1% (adjusted PR = 2.5; 
95% CI: 2.4, 2.7) among former smokers compared to 2.9% among never smokers. The most 
common chronic conditions among current smokers after age-adjustment were high cholesterol 
(36.7%), high blood pressure (34.6%), arthritis (29.4%), depression (27.4%), and asthma (16.9%). 
In separate multivariable models, smoking and COPD were associated with each of the 10 other 
chronic conditions (p < 0.05), which also included cancer, coronary heart disease, diabetes, kidney 
disease, and stroke; COPD modified associations between smoking and co-morbidities, while 
smoking did not modify associations between COPD and co-morbidities.
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Conclusions—Our findings confirm previous evidence and highlight the continuing importance 
of comprehensive care coordination for people with COPD and co-morbid chronic conditions and 
also tobacco prevention and control strategies.
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Introduction
COPD is a significant contributor to morbidity and mortality in the United States (US) (1). 
Previous epidemiologic studies suggest there are high frequencies of co-morbid chronic 
conditions among people with COPD (2–12). A recent analysis of the US National Health 
and Nutrition Examination Survey, for example, found that 96% of people aged 45 or older 
with a physician-diagnosis of chronic bronchitis or emphysema had at least one additional 
chronic condition (10).
Most previous studies have primarily focused on describing the prevalence of co-morbid 
chronic conditions among people with COPD and relevant outcomes, such as health-related 
quality of life, functional limitations, clinical outcomes, and mortality (2, 3, 6–12). Fewer 
studies, however, have assessed the role of potential shared determinants, such as cigarette 
smoking, that may link COPD and co-morbid conditions. Although the association between 
cigarette smoking with COPD and other chronic conditions is well-established, to date, few 
studies have examined the relationships between COPD and other chronic conditions by 
smoking status (13).
To better understand the relationship between smoking status and chronic conditions by 
COPD status and the relationship between COPD and other chronic conditions by smoking 
status, we used data from the 2011 Behavioral Risk Factor Surveillance System (BRFSS). 
The 2011 BRFSS provides an opportunity to estimate these relationships and to examine the 
prevalence of co-morbid chronic conditions among a large national sample of US adult 
respondents living with COPD.
Methods
Data source and sample
BRFSS (www.cdc.gov/brfss) is a state-based, random-digit-dialed telephone survey of 
noninstitutionalized, US adults aged 18 years or older, which is administered annually by 
state health departments with assistance from the US Center for Disease Control and 
Prevention (14). The 2011 BRFSS data used in this analysis reflect changes in weighting 
methodology (raking) and include both landline and cell phone respondents from the 50 
states and the District of Columbia (DC) (14). BRFSS completes more than 400,000 adult 
interviews annually, making it the largest continuously conducted health survey system in 
the world. BRFSS includes questions on sociodemographic characteristics, chronic diseases, 
health behaviors, and access to health care. BRFSS estimates have been found to be reliable 
and valid (15).
Cunningham et al. Page 2













Response rates and cooperation rates for BRFSS are calculated using standards set by the 
American Association of Public Opinion Research (www.aapor.org/
standard_definitions2.htm) (16). The median response rate, which is defined as the number 
of respondents who completed the survey as a proportion of all eligible and likely eligible 
persons, for all states and DC was 49.7% and ranged from 33.8% to 64.1% in the 2011 
survey (16). The median cooperation rate, which is defined as the number of completed 
interviews divided by the number of eligible respondents who were successfully reached by 
an interviewer, for all states and DC was 74.2% and ranged from 52.7% to 84.3% (16). 
Although low response and cooperation rates might result in non-response bias, raking in 
BRFSS serves a blanket adjustment for noncoverage and nonresponse and constrains the 
total number of cases to equal the population estimates (14). This study was exempt from 
human subjects review as the BRFSS data were publicly available. We analyzed available 
data from 405,856 respondents with complete data in 2011 for the study variables described 
next.
Measures
Current cigarette smokers were respondents who reported smoking at least 100 cigarettes 
during their lifetimes and reported smoking “every day” or “some days” at the time of the 
interview. Former smokers were those respondents who reported ever smoking at least 100 
cigarettes but reported smoking “not at all” at the time of the interview. Never smokers were 
respondents who reported smoking fewer than 100 cigarettes during their lifetimes.
BRFSS 2011 was the first time the survey included a COPD specific question. COPD was 
identified among respondents who answered yes to the question “Has a doctor, nurse, or 
other health professional ever told you that you had . . . COPD, chronic obstructive 
pulmonary disease, emphysema, or chronic bronchitis?”
We included 10 chronic conditions other than COPD that were available in BRFSS and are 
similar to those identified for the list of multiple chronic conditions by a working group 
within the Department of Health and Human Services’ Office of the Assistant Secretary of 
Health (17). These include: arthritis, asthma, cancer, coronary artery disease, depression, 
diabetes, high blood pressure, high cholesterol, kidney disease, and stroke. Respondents 
were defined as having a given chronic condition if they responded affirmatively to 
questions with the same wording used for COPD for 10 other chronic conditions, “Has a 
doctor, nurse, or other health professional ever told you that you had . . .” followed by 
individual conditions including: arthritis (some form of arthritis, rheumatoid arthritis, gout, 
lupus, or fibromyalgia); asthma; cancer (other types of cancer excluding skin cancer); 
coronary heart disease (heart attack also called a myocardial infarction, angina, or coronary 
heart disease); depression (a depressive disorder including depression, major depression, 
dysthymia, or minor depression); diabetes (diabetes other than during pregnancy, pre-
diabetes, or borderline diabetes); high blood pressure (high blood pressure other than during 
pregnancy, borderline high or pre-hypertensive); high blood cholesterol; kidney disease; or 
stroke.
Respondent characteristics that were assessed included: age group categorized using Age 
Distribution #8 (18–44, 45–54, 55–64, or ≥65 years) (18), gender (men or women), race/
Cunningham et al. Page 3













ethnicity (non-Hispanic white; non-Hispanic black; non-Hispanic Asian; non-Hispanic 
Native Hawaiian or other Pacific Islander; non-Hispanic American Indian or Alaskan 
Native; non-Hispanic other race only; non-Hispanic multiracial; or Hispanic), marital status 
(married, previously married, or never married), educational attainment (did not graduate 
high school, graduated high school or completed the general educational development 
certificate, some college or technical school, or graduated college or technical school), 
annual household income (< $25 000, $25 000–$49 999, ≥$50 000, or missing), and health 
insurance coverage (yes or no).
Data analysis
All analyses were conducted using SAS-callable SUDAAN version 11.0 (Research Triangle 
Institute, Research Triangle Park, North Carolina) to account for the complex sampling 
design of BRFSS. All estimates were weighted to represent the sampled population. Results 
were considered significant at p < 0.05 with no adjustment for multiple testing. We 
examined selected characteristics and differences in these characteristics by cigarette 
smoking status and COPD status using Chi-square tests. Estimates for the prevalence ratio 
(PR) and the corresponding 95% confidence interval (CI) for the likelihood of having COPD 
or the other chronic conditions associated with smoking status, and for the likelihood of 
having chronic diseases associated with COPD after adjustment for selected characteristics 
were determined using log-linear regression models.
Log-linear regression models can be used to estimate relative risks for binary outcomes with 
data from cross-sectional studies (19). Adjusted regression models included the following 
relevant covariates that were expected to impact the dependent variables: age group, gender, 
race/ethnicity, marital status, educational attainment, annual household income, and health 
insurance coverage. We also tested for a statistical multiplicative interaction at p < 0.05 
between cigarette smoking status and COPD on the relationship of either variable to each of 
the other chronic conditions and performed additional analyses stratified by COPD status 
and smoking status also using multivariable log-linear regression. In addition, we estimated 
the age-standardized prevalence of co-morbid chronic conditions using the projected year 
2000 US population and compared groups defined by COPD status and smoking status (18); 
statistical significance was determined using t-tests.
Results
In this study population of 405 856 respondents aged ≥18 years, 6.9% reported having 
COPD, 54.7% had never smoked cigarettes, 27.8% were former smokers, 17.5% were 
current smokers, and 71.2% reported having at least one other chronic condition. The 
distributions of selected characteristics are presented by COPD and by smoking status 
(Table 1). Compared to respondents without self-reported COPD, respondents with COPD 
were significantly (p < 0.001) more likely to be aged 45–64 years or aged ≥65 years; to be 
women; to be non-Hispanic multiracial, non-Hispanic American Indian or Alaskan Native, 
or non-Hispanic white; to be previously married; to have lower educational attainment; to 
have a household income level < $25,000; to have each of the 10 chronic conditions; and to 
have a higher number of chronic conditions. Only 5.2% of 33 088 adults with COPD 
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reported having none of the 10 chronic conditions compared to 30.8% of adults without 
COPD (p < 0.001). Adults with COPD were less likely to be an Asian or to be Hispanic than 
persons without COPD (p < 0.001). Adults with COPD were also significantly more likely 
to be either a former smoker (39.3% vs. 27.0%, p < 0.001) or a current smoker (36.7% vs. 
16.1%, p < 0.001) than adults without COPD.
Compared to respondents who reported being never cigarette smokers, current smokers were 
significantly (p < 0.001) more likely to be younger than age < 65 years; to be men; to be a 
non-Hispanic American Indian or Alaskan Native, non-Hispanic multiracial, or non-His-
panic black; to be never married or previously married; to have lower educational 
attainment; to have lower annual household income levels; to lack health insurance 
coverage; to have each of the chronic conditions; and to have a higher number of chronic 
conditions (Table 1). Current smokers were less likely than those who had never smoked to 
be Asian or Hispanic p < 0.001). Unlike the comparison between current smokers and never 
smokers, former smokers were significantly (p < 0.001) more likely than never smokers to 
be older, to be married, and to have health insurance coverage (Table 1). Compared to never 
smokers, former smokers were also significantly (p < 0.001) more likely to be men; to be 
non-Hispanic white, non-Hispanic American Indian or Alaska Native, or a non-Hispanic 
multiracial person; to have lower educational attainment; to have annual household income 
< $25,000; to have each of the 10 chronic conditions; and to have a higher number of 
chronic conditions.
The age-adjusted prevalence of COPD was 2.9% (95% CI: 2.7, 3.0) among never cigarette 
smokers, 7.1% (95% CI: 6.6, 7.6) among former smokers, and 14.1% (95% CI: 13.6, 14.7) 
among current smokers. After adjusting for age and other covariates in multivariable 
regression analyses, there was a greater likelihood of having COPD among current and 
former smokers compared to never smokers. In the analysis, the likelihood of having COPD 
was almost four times higher (PR = 3.9, 95% CI: 3.7, 4.1) among current smokers compared 
to never smokers. After adjustment for age, the most common conditions among current 
smokers were high cholesterol (36.7%), high blood pressure (34.6%), arthritis (29.4%), 
depression (27.4%), and asthma (16.9%); these were also the most common conditions 
among former smokers and never smokers (Figure 1).
There were significant interactions (p < 0.001) between smoking status and COPD for the 
associations with each of the chronic conditions. Table 2 shows the relationship of smoking 
status to each chronic disease stratified by COPD status. After taking into account all the 
covariates, current smoking was associated with a higher likelihood of arthritis, cancer, 
coronary heart disease, depression, and stroke than those who had never smoked among 
adults with no COPD. However, among adults with COPD, current smokers had a higher 
likelihood of only cancer and depression compared to those who had never smoked after 
taking into account the covariates.
The age-adjusted prevalence of each chronic condition was significantly (p < 0.001) higher 
among adults with COPD than among adults without COPD (Figure 2). The most common 
chronic conditions among adults with COPD were high cholesterol (49.3%), arthritis 
(48.8%), asthma (47.9%), high blood pressure (46.7%), and depression (42.0%). Because 
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there was a significant multiplicative interaction between COPD and smoking status for the 
associations with each chronic disease, Table 3 shows the multivariable regression analyses 
of the COPD-related likelihood of having the other chronic conditions for groups defined by 
smoking status. After adjustment for all covariates, adults with COPD had a significantly 
higher prevalence of each co-morbid condition, regardless of smoking status.
Additionally, Table 4 shows the multivariable regression analyses for the likelihood of 
having each of the other chronic diseases with all possible combinations of COPD and 
smoking status categories as a predictor (never smokers without COPD as the reference 
group). After adjustment for all covariates, current smokers with COPD had a significantly 
higher prevalence for most of the other chronic conditions in comparison to never smokers 
without COPD.
Discussion
This epidemiologic study confirms the relationship of smoking with COPD and expands on 
previous findings by relating both smoking and COPD with 10 other chronic diseases using 
the largest national US survey available. Current cigarette smokers reported approximately 
four times more COPD than never smokers and people who reported having COPD were 
significantly more likely to have each chronic condition than people who reported having no 
COPD. Interestingly, COPD appears to modify the relationship between smoking and the 
other chronic conditions. That is, the relationship between COPD and the other chronic 
conditions (e.g., arthritis, asthma, cancer, coronary artery disease, depression, diabetes, high 
blood pressure, high cholesterol, kidney disease, and stroke) persisted regardless of smoking 
status, while relationships of smoking with other chronic conditions (e.g., arthritis and 
coronary heart disease) differed between people with COPD and those without COPD.
Smoking is the leading preventable cause of COPD and several other chronic conditions, 
resulting in approximately one-half million deaths among adults and $289 billion in total 
economic costs annually in the US (20). Enhanced implementation of proven population-
level interventions, including tobacco price increases, hard-hitting anti-tobacco mass media 
campaigns, comprehensive smoke-free laws, and barrier-free access to help quitting, is 
critical to decreasing smoking and reducing the health and economic burden of tobacco-
related diseases, such as COPD (21, 22).
Our study confirms results from previous studies that observed a relatively high prevalence 
of co-morbid chronic conditions among people with COPD. In a study of 14 828 adults aged 
45 years or older included in the National Health and Nutrition Examination Survey, 96% of 
people with COPD had at least one other co-morbid chronic condition, including 60% with 
high blood pressure, 55% with arthritis, and 48% with high cholesterol (10). In another 
study of 15,792 adults aged 45–64 years from the Atherosclerosis Risk in Communities 
Study and the Cardiovascular Health Study populations, the presence of respiratory 
impairment determined by lung function measurement and presence of respiratory 
symptoms were associated with increased risk of co-morbid high blood pressure, coronary 
artery disease, and diabetes, and increased risk of having at least two of these co-morbid 
chronic conditions (8). Additionally, in a study of 341,329 adults representative of the 
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Italian population aged 45 years or older, COPD was associated with several co-morbid 
chronic conditions, including coronary artery disease, depression, diabetes, and cancer (3).
Furthermore, our study indicates there was no difference in the likelihood of some common 
chronic conditions (e.g., arthritis and coronary heart disease) among never, former, and 
current smokers with COPD, while there was a difference in the likelihood of others (e.g., 
cancer and depression). For example, we observed a 20% increased likelihood of each of 
these conditions among current smokers with COPD compared to adults with COPD who 
never smoked. In a previous prospective study, smoking modified the relationship between 
COPD and subsequent onset of depression, resulting in an increased risk of depression 
among people with COPD who smoke (23).
Equally, there is likely an increased risk of cancer among people with COPD who smoke. 
Furthermore, the lack of differentiation among people with COPD by smoking status for the 
other eight co-morbid chronic conditions examined supports the notion that oxidative stress 
and systemic inflammation are common mechanisms. According to growing evidence, 
oxidative stress and systemic inflammation are implicated as common mechanisms in the 
development and progression of COPD and also high cholesterol, arthritis, asthma, and high 
blood pressure (4, 13, 24), which we observed to be the most common co-morbid chronic 
conditions among people with COPD in this study. Research that tracks changes in 
biomarkers of oxidative stress and systemic inflammation in relation to smoking, COPD, 
and other chronic diseases and considers potential gender differences is needed to provide 
further insights. Exploratory analyses revealed that women with COPD may carry a greater 
burden of co-morbid conditions in comparison to men with COPD. Nonetheless, the role of 
smoking and its implications with respect to COPD and co-morbid conditions call attention 
to the importance of comprehensive care coordination for both women and men with 
multiple chronic conditions and evidence-based tobacco prevention and control strategies.
The findings are subject to at least three limitations. First, the information on smoking, 
COPD, chronic conditions, and other variables were collected through self-report and were 
not validated by biomarkers or medical records and might be subject to recall and other 
response biases (25). Second, the cross-sectional study design does not permit determining 
temporal sequence of cigarette smoking, COPD, and other chronic conditions and thus cause 
and effect relationships cannot be determined. Third, this study only assessed cigarette 
smoking status and not dose-response relationships or other forms of combustible tobacco 
use.
Conclusion
In summary, current and former cigarette smokers were more likely than never smokers to 
have COPD and most of the other chronic diseases examined; these associations varied 
according to COPD status. Moreover, smoking status does not modify the prevalence of the 
co-morbidities examined among respondents with COPD. Enhanced efforts in the 
coordination of care for people with COPD and co-morbidities and also the implementation 
of evidence-based tobacco prevention and control strategies could be beneficial since several 
chronic diseases share a common mechanistic pathway.
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smoking status: Behavioral Risk Factor Surveillance System, 2011.
Cunningham et al. Page 10














Age-adjusted percentages of chronic conditions among adults aged ≥18 years, by chronic 
obstructive pulmonary disease (COPD) status: Behavioral Risk Factor Surveillance System, 
2011.
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Table 2
Relationship of cigarette smoking status to other chronic conditions among adults aged >18 years, by chronic 
obstructive pulmonary disease (COPD) status: Behavioral Risk Factor Surveillance System, 2011
No COPD COPD
Chronic Disease Age-adjusted % (95% CI) Multivariable PR (95% 
CI)a
Age-adjusted % (95% CI) Multivariable PR (95% 
CI)a
Arthritis
 Never Smokerb 20.5 (20.2, 20.8) 1.0 (referent) 45.0 (42.3, 47.8) 1.0 (referent)
 Former Smokerc 24.5 (24.0, 25.1) 1.2 (1.2, 1.2) 51.0 (45.7, 56.3) 1.0 (1.0, 1.1)
 Current Smokerd 26.1 (25.4, 26.8) 1.2 (1.2, 1.3) 50.8 (48.3, 53.2) 1.0 (1.0, 1.1)
Asthma
 Never Smokerb 11.5 (11.2, 11.9) 1.0 (referent) 52.3 (48.8, 55.8) 1.0 (referent)
 Former Smokerc 12.5 (11.7, 13.3) 1.1 (1.1, 1.2) 51.8 (46.7, 56.9) 0.9 (0.8, 0.9)
 Current Smokerd 12.6 (12.0, 13.4) 1.1 (1.0, 1.1) 44.3 (41.2, 47.4) 0.8 (0.8, 0.9)
Cancer
 Never Smokerb 5.4 (5.2, 5.6) 1.0 (referent) 11.1 (9.4, 13.1) 1.0 (referent)
 Former Smokerc 6.8 (6.4, 7.2) 1.3 (1.2, 1.3) 13.4 (11.1, 16.0) 1.3 (1.2, 1.5)
 Current Smokerd 6.0 (5.7, 6.4) 1.2 (1.1, 1.3) 13.8 (12.3, 15.5) 1.2 (1.1, 1.4)
Coronary heart disease
 Never Smokerb 4.2 (4.0, 4.3) 1.0 (referent) 14.6 (13.1,16.3) 1.0 (referent)
 Former Smokerc 6.8 (6.5, 7.1) 1.4 (1.4, 1.5) 16.6 (14.8, 18.5) 1.1 (1.0, 1.2)
 Current Smokerd 6.9 (6.5, 7.3) 1.4 (1.3, 1.5) 19.1 (17.2, 21.2) 1.0 (0.9, 1.2)
Depression
 Never Smokerb 12.2 (11.9, 12.6) 1.0 (referent) 34.3 (31.2, 37.5) 1.0 (referent)
 Former Smokerc 18.0 (17.1, 18.9) 1.4 (1.3, 1.4) 39.4 (34.9, 44.2) 1.1 (1.0, 1.2)
 Current Smokerd 24.3 (23.5, 25.1) 1.7 (1.6, 1.8) 49.2 (46.1, 52.2) 1.2 (1.1, 1.3)
Diabetes
 Never Smokerb 8.8 (8.6, 9.1) 1.0 (referent) 19.5 (17.0, 22.2) 1.0 (referent)
 Former Smokerc 10.6 (10.2, 11.1) 1.2 (1.1, 1.2) 17.8 (15.7, 20.0) 1.0 (0.9, 1.1)
 Current Smokerd 9.2 (8.7, 9.6) 0.9 (0.8, 0.9) 16.6 (15.0, 18.3) 0.8 (0.7, 0.9)
High blood pressure
 Never Smokerb 29.1 (28.9, 29.5) 1.0 (referent) 48.5 (45.1, 52.1) 1.0 (referent)
 Former Smokerc 33.1 (32.4, 33.8) 1.1 (1.1, 1.1) 49.3 (43.3, 55.3) 1.0 (0.9, 1.0)
 Current Smokerd 33.0 (32.1, 33.8) 1.0 (1.0, 1.0) 44.2 (41.8, 46.7) 0.9 (0.8, 0.9)
High cholesterol
 Never Smokerb 31.0 (30.7, 31.4) 1.0 (referent) 45.6 (42.3, 48.9) 1.0 (referent)
 Former Smokerc 35.6 (34.9, 36.4) 1.1 (1.1, 1.2) 49.0 (42.9, 55.1) 1.1 (1.0, 1.1)
 Current Smokerd 34.5 (33.8, 35.3) 1.1 (1.1, 1.1) 51.4 (48.4, 54.4) 1.1 (1.0, 1.1)
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No COPD COPD
Chronic Disease Age-adjusted % (95% CI) Multivariable PR (95% 
CI)a
Age-adjusted % (95% CI) Multivariable PR (95% 
CI)a
Kidney disease
 Never Smokerb 2.1 (2.0, 2.3) 1.0 (referent) 6.3 (5.3, 7.5) 1.0 (referent)
 Former Smokerc 2.5 (2.2, 2.8) 1.2 (1.1, 1.3) 7.6 (5.1, 11.0) 0.9 (0.8, 1.1)
 Current Smokerd 2.4 (2.1, 2.6) 1.0 (0.9, 1.2) 5.6 (4.5, 6.8) 0.7 (0.6, 0.9)
Stroke
 Never Smokerb 1.9 (1.8, 2.0) 1.0 (referent) 6.4 (5.3, 7.7) 1.0 (referent)
 Former Smokerc 2.7 (2.5, 2.9) 1.4 (1.3, 1.4) 6.1 (4.8, 7.7) 1.0 (0.9, 1.2)
 Current Smokerd 3.3 (3.1, 3.6) 1.5 (1.3, 1.6) 8.9 (7.7, 10.3) 1.2 (1.0, 1.5)
a
Prevalence ratio (PR) and 95% confidence interval (CI) obtained from separate multivariable log-linear regression models that included age, 
gender, race/ethnicity, marital status, educational attainment, household income, and health insurance coverage as covariates.
b
Respondents who smoked fewer than 100 cigarettes during their lifetime were considered never smokers.
c
Respondents who smoked at least 100 cigarettes and reported smoking not at all at the time of interview were considered former smokers.
d
Respondents who smoked at least 100 cigarettes and reported smoking every day or on some days at the time of interview were considered current 
smokers.
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Table 4
Relationship of all possible combinations of chronic obstructive pulmonary disease (COPD) and cigarette 
smoking status categories to other chronic conditions among adults aged ≥18 years: Behavioral Risk Factor 
Surveillance System, 2011
COPD × Smoking Status Chronic Disease Multivariable PR (95% CI)a
Arthritis
No COPD/Never Smokerb 1.0 (referent)
No COPD/Former Smokerc 1.2 (1.2, 1.2)
No COPD/Current Smokerd 1.2 (1.2, 1.2)
COPD/Never Smokerb 1.8 (1.7, 1.8)
COPD/Former Smokerc 1.6 (1.5, 1.6)
COPD/Current Smokerd 1.8 (1.7, 1.9)
Asthma
No COPD/Never Smokerb 1.0 (referent)
No COPD/Former Smokerc 1.1 (1.0, 1.1)
No COPD/Current Smokerd 1.1 (1.0, 1.1)
COPD/Never Smokerb 4.5 (4.3, 4.8)
COPD/Former Smokerc 4.3 (4.1, 4.6)
COPD/Current Smokerd 3.7 (3.5, 3.9)
Cancer
No COPD/Never Smokerb 1.0 (referent)
No COPD/Former Smokerc 1.3 (1.2, 1.4)
No COPD/Current Smokerd 1.1 (1.1, 1.2)
COPD/Never Smokerb 1.5 (1.4, 1.7)
COPD/Former Smokerc 1.7 (1.6, 1.8)
COPD/Current Smokerd 2.0 (1.8, 2.2)
Coronary heart disease
No COPD/Never Smokerb 1.0 (referent)
No COPD/Former Smokerc 1.5 (1.4, 1.5)
No COPD/Current Smokerd 1.4 (1.3, 1.5)
COPD/Never Smokerb 3.0 (2.7, 3.3)
COPD/Former Smokerc 2.7 (2.5, 2.9)
COPD/Current Smokerd 3.1 (2.9, 3.4)
Depression
No COPD/Never Smokerb 1.0 (referent)
No COPD/Former Smokerc 1.4 (1.3, 1.4)
No COPD/Current Smokerd 1.7 (1.6, 1.8)
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COPD × Smoking Status Chronic Disease Multivariable PR (95% CI)a
COPD/Never Smokerb 2.3 (2.1, 2.4)
COPD/Former Smokerc 2.3 (2.2, 2.4)
COPD/Current Smokerd 2.6 (2.5, 2.8)
Diabetes
No COPD/Never Smokerb 1.0 (referent)
No COPD/Former Smokerc 1.2 (1.1, 1.2)
No COPD/Current Smokerd 0.9 (0.8, 0.9)
COPD/Never Smokerb 1.7 (1.6, 1.9)
COPD/Former Smokerc 1.5 (1.4, 1.6)
COPD/Current Smokerd 1.4 (1.3, 1.5)
High blood pressure
No COPD/Never Smokerb 1.0 (referent)
No COPD/Former Smokerc 1.1 (1.1, 1.1)
No COPD/Current Smokerd 1.0 (1.0, 1.0)
COPD/Never Smokerb 1.4 (1.4, 1.5)
COPD/Former Smokerc 1.3 (1.2, 1.3)
COPD/Current Smokerd 1.2 (1.2, 1.3)
High cholesterol
No COPD/Never Smokerb 1.0 (referent)
No COPD/Former Smokerc 1.1 (1.1, 1.2)
No COPD/Current Smokerd 1.1 (1.0, 1.1)
COPD/Never Smokerb 1.3 (1.3, 1.4)
COPD/Former Smokerc 1.3 (1.3, 1.4)
COPD/Current Smokerd 1.4 (1.4, 1.5)
Kidney disease
No COPD/Never Smokerb 1.0 (referent)
No COPD/Former Smokerc 1.2 (1.1, 1.3)
No COPD/Current Smokerd 1.0 (0.9, 1.2)
COPD/Never Smokerb 2.5 (2.2, 2.9)
COPD/Former Smokerc 2.2 (1.9, 2.5)
COPD/Current Smokerd 2.8 (1.6, 2.1)
Stroke
No COPD/Never Smokerb 1.0 (referent)
No COPD/Former Smokerc 1.4 (1.3, 1.5)
No COPD/Current Smokerd 1.5 (1.3, 1.6)
COPD/Never Smokerb 2.3 (2.0, 2.7)
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COPD × Smoking Status Chronic Disease Multivariable PR (95% CI)a
COPD/Former Smokerc 2.2 (1.9, 2.4)
COPD/Current Smokerd 2.9 (2.6, 3.2)
a
Prevalence ratio (PR) and 95% confidence interval (CI) obtained from separate multivariable log-linear regression models for each chronic 
condition that included all possible combinations of COPD and status smoking categories as a predictor when entered simultaneously with age, 
gender, race/ethnicity, marital status, educational attainment, household income, and health insurance coverage as covariates.
b
Respondents who smoked fewer than 100 cigarettes during their lifetime were considered never smokers.
c
Respondents who smoked at least 100 cigarettes and reported smoking not at all at the time of interview were considered former smokers.
d
Respondents who smoked at least 100 cigarettes and reported smoking every day or on some days at the time of interview were considered current 
smokers.
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